Fructose induces prothrombotic phenotype in human endothelial cells : A new role for "added sugar" in cardio-metabolic risk (Q40806527)

23 September 2017

Fructose induces prothrombotic phenotype in human endothelial cells : A new role for "added sugar" in cardio-metabolic risk (English)

1 reference

23 September 2017

0 references

5

1 reference

23 September 2017

7

1 reference

23 September 2017

Antonio Leonardi

6

0 references

Plinio Cirillo

object named as

Plinio Cirillo

series ordinal

1

0 references

Stefano Dal Conte

series ordinal

3

object named as

Stefano Conte

1 reference

23 September 2017

Grazia Pellegrino

2

1 reference

PubMed ID

26104185

23 September 2017

Fabio Maresca

series ordinal

4

1 reference

23 September 2017

24 June 2015

1 reference

23 September 2017

8

1 reference

Journal of Thrombosis and Thrombolysis

inferred from page(s)

published in

1 reference

23 September 2017

40

1 reference

23 September 2017

444-451

1 reference

23 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11239-015-1243-1

23 September 2017

0 references

cites work

Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Obesity as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Metabolic effects of fructose and the worldwide increase in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Fructose: a key factor in the development of metabolic syndrome and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Effect of fructose on glycemic control in diabetes: a systematic review and meta-analysis of controlled feeding trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Fructose and risk of cardiometabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Cellular adhesion molecules and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Implications of early structural-functional changes in the endothelium for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Fructose induces the inflammatory molecule ICAM-1 in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

LPS and cytokine-activated endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Pro-atherothrombotic effects of leptin in human coronary endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

The adipokine apelin-13 induces expression of prothrombotic tissue factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Cell-specific insulin resistance: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Felodipine attenuates vascular inflammation in a fructose-induced rat model of metabolic syndrome via the inhibition of NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Modulation of tissue factor and thrombomodulin expression in human aortic endothelial cells incubated with high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Redox regulation of NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Role of tissue factor in embryonic blood vessel development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

The relationship between tissue factor and cancer progression: insights from bench and bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Sucrose, fructose, glucose, and their link to metabolic syndrome and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-015-1243-1

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

21 January 2018

1 reference

12 December 2020

Heat shock of vascular endothelial cells induces an up-regulatory transcriptional response of the thrombomodulin gene that is delayed in onset and does not attenuate

1 reference

12 December 2020

Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion

1 reference

12 December 2020

Activation of blood coagulation in cancer: implications for tumour progression

1 reference

12 December 2020

Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects

1 reference

12 December 2020

Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro.

1 reference

12 December 2020

Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis

1 reference

12 December 2020

Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris

1 reference

12 December 2020

Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content

1 reference

12 December 2020

10.1007/S11239-015-1243-1

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

26104185